FilingSEC EDGAR8-K
Standard BioTools Completes Sale of Microfluidics Business
· SEC accepted
StageCompleted
Filing content
Standard BioTools has completed the sale of its Microfluidics business to ARCHIMED. The business will now operate as an independent entity named Biomark Scientific.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…